Stock Analyses

Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.

All sectors 6,479 Financial Services 1,900 Healthcare 1,116 Technology 1,079 Industrials 668 Consumer Cyclical 490 Basic Materials 337 Consumer Defensive 248 Communication Services 213 Utilities 183 Energy 165 Real Estate 80
Clear
6,990 stocks · page 8 of 117
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
APACR
StoneBridge Acquisition II Corp
Valuation N/A
Financial Services
Price$0.12
Model IV—
P/IV—
APACU
StoneBridge Acquisition II Corp
Valuation N/A
Financial Services
Price$10.39
Model IV—
P/IV—
APAM
Artisan Partners Asset Management Inc.
Fairly valued
Financial Services
Price$36.68
Model IV$41.38
P/IV0.90
Discount 11% Return to IV: +12.8%
Owner yield 11.0% 10-yr IRR 17.6% · steady
Market implies +0.9%/yr vs model +3.0% · in line
APC
ARKO Petroleum Corp.
Valuation N/A
Consumer Defensive
Price$18.82
Model IV—
P/IV—
APD
Air Products & Chemicals, Inc.
Deeply overvalued
Basic Materials
Price$284.18
Model IV$82.59
P/IV3.53
Premium +244% Return to IV: -70.9%
Market implies +20.4%/yr vs model +4.2% · above model
APEI
AMERICAN PUBLIC EDUCATION INC
Undervalued
Consumer Defensive
Price$43.88
Model IV$53.23
P/IV0.93
Discount 18% Return to IV: +21.3%
Owner yield 4.3% 10-yr IRR 8.7% · moderate
Market implies +4.3%/yr vs model +9.6% · below model
APG
APi Group Corp
Fairly valued
Technology
Price$37.39
Model IV$37.65
P/IV1.10
Discount 1% Return to IV: +0.7%
Owner yield 3.5% 10-yr IRR 9.9% · grower
Market implies +13.1%/yr vs model +16.9% · below model
APGE
Apogee Therapeutics, Inc.
Valuation N/A
Healthcare
Price$135.07
Model IV—
P/IV—
APH
AMPHENOL CORP /DE/
Fairly valued
Technology
Price$77.55
Model IV$74.05
P/IV2.01
Premium +5% Return to IV: -4.5%
Owner yield 2.9% 10-yr IRR 7.6% · grower
Market implies +14.8%/yr vs model +18.1% · below model
API
Agora, Inc.
Valuation N/A
Technology
Price$4.00
Model IV—
P/IV—
Market implies +27.9%/yr vs model +5.7% · above model
APLD
Applied Digital Corp.
Valuation N/A
Technology
Price$28.12
Model IV—
P/IV—
Market implies +69.4%/yr vs model +15.0% · above model
APLE
Apple Hospitality REIT, Inc.
Fairly valued
Financial Services
Price$15.58
Model IV$18.31
P/IV0.80
Discount 15% Return to IV: +17.5%
APLM
Apollomics Inc.
Valuation N/A
Healthcare
Price$23.42
Model IV—
P/IV—
APLMW
Apollomics Inc.
Valuation N/A
Healthcare
Price$0.01
Model IV—
P/IV—
APM
Aptorum Group Ltd
Valuation N/A
Healthcare
Price$8.41
Model IV—
P/IV—
Market implies +61.6%/yr vs model +15.0% · above model
APO
Apollo Global Management, Inc.
Deeply undervalued
Financial Services
Price$125.91
Model IV$428.25
P/IV0.30
Discount 71% Return to IV: +240.1%
Market implies +1.9%/yr vs model +25.0% · below model
APOG
APOGEE ENTERPRISES, INC.
Deeply undervalued
Industrials
Price$36.80
Model IV$57.42
P/IV0.67
Discount 36% Return to IV: +56.0%
Owner yield 14.6% 10-yr IRR 26.5% · moderate
Market implies -1.6%/yr vs model +7.0% · below model
APOS
Apollo Global Management, Inc.
Valuation N/A
Financial Services
Price$25.55
Model IV—
P/IV—
Market implies -28.4%/yr vs model +25.0% · below model
APP
AppLovin Corp
Deeply overvalued
Technology
Price$308.06
Model IV$179.74
P/IV3.41
Premium +71% Return to IV: -41.7%
Owner yield 2.3% 10-yr IRR 4.3% · grower
Market implies +21.2%/yr vs model +16.5% · above model
APPF
APPFOLIO INC
Fairly valued
Technology
Price$214.63
Model IV$246.59
P/IV0.65
Discount 13% Return to IV: +14.9%
Owner yield 2.0% 10-yr IRR 3.1% · grower
Market implies +15.4%/yr vs model +22.9% · below model
APPN
APPIAN CORP
Deeply overvalued
Technology
Price$37.52
Model IV$7.95
P/IV2.94
Premium +372% Return to IV: -78.8%
Market implies +32.7%/yr vs model +16.5% · above model
APPS
Digital Turbine, Inc.
Deeply overvalued
Financial Services
Price$10.66
Model IV$2.47
P/IV3.55
Premium +331% Return to IV: -76.8%
APRE
Aprea Therapeutics, Inc.
Valuation N/A
Healthcare
Price$0.76
Model IV—
P/IV—
APT
ALPHA PRO TECH LTD
Undervalued
Healthcare
Price$5.11
Model IV$7.15
P/IV0.81
Discount 29% Return to IV: +39.9%
Owner yield 7.0% 10-yr IRR 13.7% · moderate
Market implies -0.5%/yr vs model +7.0% · below model
APTV
Aptiv PLC
Deeply undervalued
Consumer Cyclical
Price$43.59
Model IV$65.09
P/IV1.04
Discount 33% Return to IV: +49.3%
Owner yield 14.3% 10-yr IRR 26.4% · moderate
Market implies 0.0%/yr vs model +7.2% · below model
APUS
Apimeds Pharmaceuticals US, Inc.
Valuation N/A
Healthcare
Price$1.77
Model IV—
P/IV—
APVO
Aptevo Therapeutics Inc.
Valuation N/A
Healthcare
Price$1.84
Model IV—
P/IV—
Market implies -18.8%/yr vs model +15.0% · below model
APWC
ASIA PACIFIC WIRE & CABLE CORP LTD
Deeply undervalued
Basic Materials
Price$1.34
Model IV$7.10
P/IV0.20
Discount 81% Return to IV: +429.5%
Owner yield 9.8% 10-yr IRR 17.5% · steady
Market implies -22.7%/yr vs model +5.0% · below model
APXT
Apex Treasury Corp
Valuation N/A
Financial Services
Price$10.14
Model IV—
P/IV—
APXTU
Apex Treasury Corp
Valuation N/A
Financial Services
Price$10.29
Model IV—
P/IV—
APXTW
Apex Treasury Corp
Valuation N/A
Financial Services
Price$0.29
Model IV—
P/IV—
APYX
Apyx Medical Corp
Valuation N/A
Healthcare
Price$3.06
Model IV—
P/IV—
Market implies +29.3%/yr vs model +2.2% · above model
AQB
AQUABOUNTY TECHNOLOGIES INC
Valuation N/A
Basic Materials
Price$1.14
Model IV—
P/IV—
Market implies +33.2%/yr vs model +8.0% · above model
AQMS
Aqua Metals, Inc.
Valuation N/A
Basic Materials
Price$2.37
Model IV—
P/IV—
Market implies +54.3%/yr vs model +5.0% · above model
AQN
ALGONQUIN POWER & UTILITIES CORP.
Deeply overvalued
Utilities
Price$5.35
Model IV$4.08
P/IV1.44
Premium +31% Return to IV: -23.7%
AQNB
ALGONQUIN POWER & UTILITIES CORP.
Valuation N/A
Utilities
Price$26.25
Model IV—
P/IV—
AQST
Aquestive Therapeutics, Inc.
Valuation N/A
Healthcare
Price$4.61
Model IV—
P/IV—
Market implies +47.4%/yr vs model +2.0% · above model
AR
ANTERO RESOURCES Corp
Fairly valued
Energy
Price$34.86
Model IV$33.27
P/IV1.07
Premium +5% Return to IV: -4.6%
Market implies -2.5%/yr vs model +0.0% · in line
ARAI
Arrive AI Inc.
Valuation N/A
Technology
Price$0.24
Model IV—
P/IV—
Market implies +64.2%/yr vs model +15.0% · above model
ARAY
ACCURAY INC
Valuation N/A
Healthcare
Price$0.23
Model IV—
P/IV—
Market implies -50.0%/yr vs model +3.7% · below model
ARBB
ARB IOT Group Ltd
Valuation N/A
Technology
Price$4.63
Model IV—
P/IV—
ARBE
Arbe Robotics Ltd.
Valuation N/A
Technology
Price$0.67
Model IV—
P/IV—
Market implies +66.3%/yr vs model +2.0% · above model
ARBEW
Arbe Robotics Ltd.
Valuation N/A
Technology
Price$0.01
Model IV—
P/IV—
Market implies +15.0%/yr vs model +2.0% · above model
ARBK
Argo Blockchain Plc
Valuation N/A
Financial Services
Price$2.75
Model IV—
P/IV—
ARCB
ARCBEST CORP /DE/
Deeply overvalued
Industrials
Price$128.73
Model IV$58.25
P/IV2.35
Premium +121% Return to IV: -54.8%
Owner yield 3.2% 10-yr IRR 2.7% · moderate
Market implies +17.2%/yr vs model +6.8% · above model
ARCC
ARES CAPITAL CORP
Valuation N/A
Unknown
Price$19.40
Model IV—
P/IV—
ARCI
Archimedes Tech SPAC Partners III Co.
Valuation N/A
Financial Services
Price$10.10
Model IV—
P/IV—
ARCIU
Archimedes Tech SPAC Partners III Co.
Valuation N/A
Financial Services
Price$10.40
Model IV—
P/IV—
ARCIW
Archimedes Tech SPAC Partners III Co.
Valuation N/A
Financial Services
Price$0.42
Model IV—
P/IV—
ARCL
ARC Group Acquisition I Corp.
Valuation N/A
Financial Services
Price$10.00
Model IV—
P/IV—
ARCLU
ARC Group Acquisition I Corp.
Valuation N/A
Financial Services
Price$10.22
Model IV—
P/IV—
ARCO
Arcos Dorados Holdings Inc.
Deeply undervalued
Consumer Cyclical
Price$7.53
Model IV$32.12
P/IV0.27
Discount 77% Return to IV: +326.6%
Market implies -26.7%/yr vs model +15.2% · below model
ARCT
Arcturus Therapeutics Holdings Inc.
Deeply undervalued
Healthcare
Price$16.03
Model IV$50.73
P/IV0.16
Discount 68% Return to IV: +216.5%
Market implies -19.0%/yr vs model +50.0% · below model
ARDC
Ares Dynamic Credit Allocation Fund, Inc.
Valuation N/A
Unknown
Price$12.01
Model IV—
P/IV—
ARDT
Ardent Health, Inc.
Deeply undervalued
Healthcare
Price$10.48
Model IV$37.62
P/IV0.25
Discount 72% Return to IV: +259.0%
Market implies -13.3%/yr vs model +8.1% · below model
ARDX
ARDELYX, INC.
Deeply undervalued
Healthcare
Price$3.42
Model IV$13.06
P/IV1.19
Discount 74% Return to IV: +281.9%
Market implies -22.2%/yr vs model +50.0% · below model
ARE
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Deeply undervalued
Financial Services
Price$53.30
Model IV$90.72
P/IV0.55
Discount 41% Return to IV: +70.2%
AREC
American Resources Corp
Valuation N/A
Energy
Price$1.98
Model IV—
P/IV—
Market implies +53.7%/yr vs model +4.0% · above model
AREN
Arena Group Holdings, Inc.
Deeply undervalued
Communication Services
Price$1.03
Model IV$5.83
P/IV2.85
Discount 82% Return to IV: +466.1%
Market implies -38.7%/yr vs model -3.3% · below model
ARES
Ares Management Corp
Deeply overvalued
Financial Services
Price$123.80
Model IV$63.59
P/IV2.02
Premium +95% Return to IV: -48.6%
Market implies +15.9%/yr vs model +7.6% · above model